IVVD — Invivyd, Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1832038 ·
Last close
$0.93
Market Cap
$275.30M
52W High
$3.07
52W Low
$0.53
ADV30
4,936,203
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 14,285,000 | 13,012,000 | -45,820,000 | -44,393,000 | 218,883,000 | 160,080,000 | 37,803,000 |
| Mar 2026 | 13,744,000 | 12,712,000 | -43,136,000 | -41,400,000 | 241,742,000 | 184,153,000 | 38,692,000 |
| Dec 2025 | 17,207,000 | 16,067,000 | -12,555,000 | -11,070,000 | 276,883,000 | 226,689,000 | 35,343,000 |
| Sep 2025 | 13,129,000 | 12,041,000 | -11,023,000 | -10,470,000 | 139,158,000 | 84,967,000 | 46,090,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-78,718,000
Investing CF
$-737,000
Financing CF
$215,522,000
CapEx
$-881,000
Dividends Paid
—
Buybacks
$-231,000
EPS Diluted TTM
$-0.45
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-995,883,000
Inventory
$262,000
Receivables
$12,209,000
ST Investments
—
EBIT TTM
$-81,774,000
Pretax Income TTM
$-77,600,000
Interest Exp TTM
—
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$58,365,000
EBITDA
$-111,888,000
Free Cash Flow
$-69,950,752
Enterprise Value
$79,843,992
Total Cash
$160,080,000
Total Debt
$8,391,000
Shares Out
294,758,746
Trailing EPS
$-0.31
Book Value
$0.61
ROE
-95.9%
ROA
-45.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 53,426,000 | -55,560,000 | -52,489,000 | 276,883,000 | 35,343,000 | 241,540,000 | -58,135,000 |
| Dec 2024 | 25,384,000 | -176,876,000 | -169,925,000 | 129,515,000 | 61,976,000 | 67,539,000 | -170,491,000 |
| Dec 2023 | 0 | -207,783,000 | -198,643,000 | 229,181,000 | 51,713,000 | 177,468,000 | -173,164,000 |
| Dec 2022 | 0 | -226,258,000 | -241,317,000 | 383,167,000 | 27,197,000 | 355,970,000 | -219,987,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.55
Max Pain — expiry 2026-10-16
max pain strike: $0.50 · spot: $0.97 · call oi: 11,718 · put oi: 384
Expected Move to 2026-10-16:
±$0.47
(49.04%) —
implied range
$0.49 –
$1.44
· ATM straddle on $1.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LXEO | Lexeo Therapeutics, Inc. | $271.57M | $3.31 | — |
| FATE | FATE THERAPEUTICS INC | $281.58M | $2.35 | — |
| STRO | SUTRO BIOPHARMA, INC. | $264.97M | $15.98 | — |
| IKT | Inhibikase Therapeutics, Inc. | $287.44M | $2.06 | — |
| LCTX | Lineage Cell Therapeutics, Inc. | $260.49M | $1.03 | — |
News headlines (Yahoo Finance, 1h cache)
3 Small-Cap Biotechs With Binary Catalysts on the Calendar
2026-09-13 14:50 · Yahoo
Invivyd to Participate in Upcoming September Investor Conferences
2026-09-08 11:01 · Yahoo
Invivyd Appoints Chairman Marc W. Elia as Chief Executive Officer; Approaches Results of VYD2311 studies DECLARATION and LIBERTY
2026-09-01 11:01 · Yahoo
Invivyd Announces Receipt of Twelve Months’ Advanced Notice of Emergency Use Authorization (EUA) Termination for PEMGARDA® and Provides an Update on Next Steps with the U.S. FDA
2026-07-06 11:01 · Yahoo
Invivyd (IVVD) Doses First Participants in Phase 3 Trial for VYD2311
2026-06-19 07:00 · Yahoo
Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine
2026-06-16 11:01 · Yahoo
Invivyd doses first participants in Phase 3 COVID-19 trial
2026-06-09 16:22 · Yahoo
This Invivyd Insider Increased Their Holding In The Last Year
2026-06-06 13:11 · Yahoo
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-06-03 11:01 · Yahoo
Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID
2026-06-01 11:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.